Tumor necrosis factor-alpha (TNF-α) inhibitors are effective treatments for IMIDs such rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ulcerative colitis, psoriasis, Crohn’s disease and ankylosing spondylitis. The gene discussed is TNF; the disease is ulcerative colitis.